{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:30:48Z","timestamp":1793046648949,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mycophenolic acid (MPA) is the most widely used immunosuppressive drug in transplantation and for autoimmune diseases. Unfortunately, more than 30% of patients experience a typical gastrointestinal adverse effect also referred to as mycophenolate-induced enteropathy. Due to its antibacterial, antifungal, and antiviral properties, MPA exposure is associated with intestinal dysbiosis characterized by a decrease in density and diversity of the microbiome regarding the main bacterial phyla (Firmicutes and Bacteroidetes). These bacterial phyla are known for their metabolic role in maintaining the homeostasis of the digestive tract, particularly through the production of short-chain fatty acids (SCFA) that could contribute to the pathophysiology of mycophenolate-induced enteropathy. Our study aimed at deciphering short-chain fatty acids (SCFA) profile alterations associated with gastrointestinal toxicity of MPA at the digestive and systemic levels in a mouse model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Ten-week old C57BL\/6 (SOPF) mice were randomly assigned in 2 groups of 9 subjects: control, and mycophenolate mofetil (MMF, 900\u2009mg\/kg\/day). All mice were daily treated by oral gavage for 7\u2009days. Individual faecal pellets were collected at days 0, 4 and 8 as well as plasma at day 8 for SCFA profiling. Additionally, after the sacrifice on day 8, the caecum was weighted, and colon length was measured. The proximal colon was cut for histological analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MMF treatment induced around 10% weight loss at the end of the protocol associated with a significant decrease in caecum weight and a slight reduction in colon length. Histological analysis showed significant architectural changes in colon epithelium. Moreover, we observed an overall decrease in SCFA concentrations in faecal samples, especially regarding acetate (at day 8, control 1040.6 \u00b1 278.161\u2009\u03bcM versus MMF 384.7 \u00b1 80.5\u2009\u03bcM,<jats:italic>p<\/jats:italic>&lt; 0.01) and propionate (at day 8, control 185.94 \u00b1 51.96\u2009\u03bcM versus MMF 44.07 \u00b1 14.66\u2009\u03bcM,<jats:italic>p<\/jats:italic>&lt; 0.001), and in plasma samples for butyrate (at day 8, control 0.91 \u00b1 0.1\u2009\u03bcM versus MMF 0.46 \u00b1 0.1\u2009\u03bcM,<jats:italic>p &lt;<\/jats:italic>0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results are consistent with functional impairment of the gut microbiome linked with digestive or systemic defects during MMF treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40360-021-00536-4","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T15:02:42Z","timestamp":1635433362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-1566","authenticated-orcid":false,"given":"Manon","family":"Jardou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Brossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-2661","authenticated-orcid":false,"given":"\u00c9milie","family":"Pinault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5942-7824","authenticated-orcid":false,"given":"Fran\u00e7ois-Ludovic","family":"Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0684-8809","authenticated-orcid":false,"given":"Roland","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"issue":"7","key":"536_CR1","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/S0041-1345(02)03538-8","volume":"34","author":"AC Allison","year":"2002","unstructured":"Allison AC. Mechanisms of action of mycophenolate mofetil in preventing chronic rejection. Transplant Proc. 2002;34(7):2863\u20136.","journal-title":"Transplant Proc"},{"issue":"12","key":"536_CR2","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1517\/14656566.4.12.2325","volume":"4","author":"TR Srinivas","year":"2005","unstructured":"Srinivas TR, Kaplan B, Meier-Kriesche H-U. Mycophenolate mofetil in solid-organ transplantation. Expert Opin Pharmacother. 2005;4(12):2325\u201345.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"536_CR3","first-page":"91","volume":"62","author":"G Zizzo","year":"2010","unstructured":"Zizzo G, De Santis M, Ferraccioli GF. Mycophenolic acid in rheumatology: mechanisms of action and severe adverse events. Reumatismo. 2010;62(2):91\u2013100.","journal-title":"Reumatismo."},{"issue":"2\u20133","key":"536_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47(2\u20133):85\u2013118.","journal-title":"Immunopharmacology."},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mrgentox.2016.10.002","volume":"810","author":"H Ferjani","year":"2016","unstructured":"Ferjani H, Draz H, Abid S, Achour A, Bacha H, Boussema-Ayed I. Combination of tacrolimus and mycophenolate mofetil induces oxidative stress and genotoxicity in spleen and bone marrow of Wistar rats. Mutat Res Toxicol Environ Mutagen. 2016;810:48\u201355.","journal-title":"Mutat Res Toxicol Environ Mutagen"},{"issue":"2","key":"536_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-3083.1991.tb03747.x","volume":"33","author":"EM Eugui","year":"1991","unstructured":"Eugui EM, Mirkovich A, Allison AC. Lymphocyte-selective Antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol. 1991;33(2):175\u201383.","journal-title":"Scand J Immunol"},{"issue":"3","key":"536_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0190-9622(18)30747-3","volume":"37","author":"JES Kitchin","year":"1997","unstructured":"Kitchin JES, Pomeranz MK, Pak G, Washenik K, Shupack JL. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses. J Am Acad Dermatol. 1997;37(3):445\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"536_CR8","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1016\/j.transproceed.2010.08.066","volume":"42","author":"AI Al-Absi","year":"2010","unstructured":"Al-Absi AI, Cooke CR, Wall BM, Sylvestre P, Ismail MK, Mya M. Patterns of injury in mycophenolate Mofetil\u2013related colitis. Transplant Proc. 2010;42(9):3591\u20133.","journal-title":"Transplant Proc"},{"issue":"9","key":"536_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","volume":"24","author":"M Behrend","year":"2001","unstructured":"Behrend M. Adverse gastrointestinal effects of mycophenolate Mofetil. Drug Saf. 2001;24(9):645\u201363.","journal-title":"Drug Saf"},{"issue":"1","key":"536_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.gie.2013.08.027","volume":"79","author":"J Seminerio","year":"2014","unstructured":"Seminerio J, McGrath K, Arnold CA, Voltaggio L, Singhi AD. Medication-associated lesions of the GI tract. Gastrointest Endosc. 2014;79(1):140\u201350.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"536_CR11","first-page":"366","volume":"28","author":"FH Calmet","year":"2015","unstructured":"Calmet FH, Yarur AJ, Pukazhendhi G, Ahmad J, Bhamidimarri KR. Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation. Ann Gastroenterol Q Publ Hell Soc Gastroenterol. 2015;28(3):366.","journal-title":"Ann Gastroenterol Q Publ Hell Soc Gastroenterol"},{"issue":"6","key":"536_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/modpathol.2009.44","volume":"22","author":"MK Selbst","year":"2009","unstructured":"Selbst MK, Ahrens WA, Robert ME, Friedman A, Proctor DD, Jain D. Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil. Mod Pathol. 2009;22(6):737\u201343.","journal-title":"Mod Pathol"},{"issue":"1","key":"536_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/TP.0000000000001492","volume":"101","author":"J Tourret","year":"2017","unstructured":"Tourret J, Willing BP, Dion S, MacPherson J, Denamur E, Finlay BB. Immunosuppressive treatment alters secretion of ileal antimicrobial peptides and gut microbiota, and favors subsequent colonization by uropathogenic Escherichia coli. Transplantation. 2017;101(1):74\u201382.","journal-title":"Transplantation."},{"key":"536_CR14","doi-asserted-by":"crossref","unstructured":"Gibson CM, Childs-Kean LM, Naziruddin Z, Howell CK. The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation. Transpl Infect Dis. 2021;23:e13397.","DOI":"10.1111\/tid.13397"},{"issue":"8","key":"536_CR15","doi-asserted-by":"publisher","first-page":"eaax2358","DOI":"10.1126\/sciadv.aax2358","volume":"5","author":"MR Taylor","year":"2019","unstructured":"Taylor MR, Flannigan KL, Rahim H, Mohamud A, Lewis IA, Hirota SA, et al. Vancomycin relieves mycophenolate mofetil\u2013induced gastrointestinal toxicity by eliminating gut bacterial \u03b2-glucuronidase activity. Sci Adv. 2019;5(8):eaax2358.","journal-title":"Sci Adv"},{"issue":"9","key":"536_CR16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.healun.2018.05.002","volume":"37","author":"KL Flannigan","year":"2018","unstructured":"Flannigan KL, Taylor MR, Pereira SK, Rodriguez-Arguello J, Moffat AW, Alston L, et al. An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil. J Heart Lung Transplant. 2018;37(9):1047\u201359.","journal-title":"J Heart Lung Transplant"},{"key":"536_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"536_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41396-021-00937-7","volume":"15","author":"N Tsukuda","year":"2021","unstructured":"Tsukuda N, Yahagi K, Hara T, Watanabe Y, Matsumoto H, Mori H, et al. Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life. ISME J. 2021;15:1\u201317.","journal-title":"ISME J"},{"issue":"6","key":"536_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/ismej.2014.14","volume":"8","author":"N Reichardt","year":"2014","unstructured":"Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014;8(6):1323\u201335.","journal-title":"ISME J"},{"issue":"1","key":"536_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-018-0034-5","volume":"4","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther. 2019;4(1):1\u201334.","journal-title":"Signal Transduct Target Ther"},{"issue":"Pt 2","key":"536_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1113\/jphysiol.2001.014241","volume":"539","author":"MA Cuff","year":"2002","unstructured":"Cuff MA, Lambert DW, Shirazi-Beechey SP. Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J Physiol. 2002;539(Pt 2):361.","journal-title":"J Physiol"},{"issue":"14","key":"536_CR22","doi-asserted-by":"publisher","first-page":"13293","DOI":"10.1074\/jbc.C400059200","volume":"279","author":"S Miyauchi","year":"2004","unstructured":"Miyauchi S, Gopal E, Fei Y-J, Ganapathy V. Functional identification of SLC5A8, a tumor suppressor Down-regulated in Colon Cancer, as a Na+\u2212coupled transporter for short-chain fatty acids. J Biol Chem. 2004;279(14):13293\u20136.","journal-title":"J Biol Chem"},{"key":"536_CR23","first-page":"846","volume":"289","author":"RK Gill","year":"2005","unstructured":"Gill RK, Saksena S, Alrefai WA, Sarwar Z, Goldstein JL, Carroll RE, et al. Expression and membrane localization of MCT isoforms along the length of the human intestine. Am J Phys Cell Phys. 2005;289:846\u201352.","journal-title":"Am J Phys Cell Phys"},{"issue":"13","key":"536_CR24","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.M211609200","volume":"278","author":"AJ Brown","year":"2003","unstructured":"Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312\u20139.","journal-title":"J Biol Chem"},{"issue":"3","key":"536_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/mi.2017.118","volume":"11","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Chen F, Wu W, Sun M, Bilotta AJ, Yao S, et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 2018;11(3):752\u201362.","journal-title":"Mucosal Immunol"},{"issue":"7","key":"536_CR26","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","volume":"69","author":"M Thangaraju","year":"2009","unstructured":"Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009;69(7):2826.","journal-title":"Cancer Res"},{"issue":"28","key":"536_CR27","doi-asserted-by":"publisher","first-page":"25481","DOI":"10.1074\/jbc.M301403200","volume":"278","author":"E Le Poul","year":"2003","unstructured":"Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in Polymorphonuclear cell activation. J Biol Chem. 2003;278(28):25481\u20139.","journal-title":"J Biol Chem"},{"key":"536_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","volume":"29","author":"B Van Der Hee","year":"2021","unstructured":"Van Der Hee B, Wells JM. Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol. 2021;29:700\u201312.","journal-title":"Trends Microbiol"},{"issue":"6","key":"536_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1101\/gr.5540007","volume":"17","author":"A Rada-Iglesias","year":"2007","unstructured":"Rada-Iglesias A, Enroth S, Ameur A, Koch CM, Clelland GK, Respuela-Alonso P, et al. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res. 2007;17(6):708.","journal-title":"Genome Res"},{"issue":"5","key":"536_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1091-255X(00)80093-1","volume":"4","author":"MD Basson","year":"2000","unstructured":"Basson MD, Liu YW, Hanly AM, Emenaker NJ, Shenoy SG, Rothberg BEG. Identification and comparative analysis of human colonocyte short-chain fatty acid response genes. J Gastrointest Surg. 2000;4(5):501\u201312.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"536_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","volume":"14","author":"EPM Candido","year":"1978","unstructured":"Candido EPM, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell. 1978;14(1):105\u201313.","journal-title":"Cell."},{"issue":"1","key":"536_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0092-8674(78)90306-9","volume":"14","author":"L Sealy","year":"1978","unstructured":"Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell. 1978;14(1):115\u201321.","journal-title":"Cell."},{"issue":"37","key":"536_CR33","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","volume":"26","author":"WS Xu","year":"2007","unstructured":"Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007;26(37):5541\u201352.","journal-title":"Oncogene"},{"key":"536_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"50","author":"J Schulthess","year":"2019","unstructured":"Schulthess J, Pandey S, Capitani M. The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity. 2019;50:432\u2013445.e7.","journal-title":"Immunity"},{"issue":"5","key":"536_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","volume":"13","author":"DR Donohoe","year":"2011","unstructured":"Donohoe DR, Garge N, Zhang X, Sun W, O\u2019Connell TM, Bunger MK, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian Colon. Cell Metab. 2011;13(5):517\u201326.","journal-title":"Cell Metab"},{"issue":"12","key":"536_CR36","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","volume":"57","author":"HB Wang","year":"2012","unstructured":"Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein claudin-1 transcription. Dig Dis Sci. 2012;57(12):3126\u201335.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"536_CR37","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","volume":"52","author":"LEM Willemsen","year":"2003","unstructured":"Willemsen LEM, Koetsier MA, van Deventer SJH, van Tol EAF. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut. 2003;52(10):1442.","journal-title":"Gut."},{"issue":"16","key":"536_CR38","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1111\/bph.15178","volume":"177","author":"E Lilley","year":"2020","unstructured":"Lilley E, Stanford SC, Kendall DE, Alexander SPH, Cirino G, Docherty JR, et al. ARRIVE 2.0 and the British Journal of pharmacology: updated guidance for 2020. Br J Pharmacol. 2020;177(16):3611\u20136.","journal-title":"Br J Pharmacol"},{"key":"536_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.aca.2014.11.015","volume":"854","author":"J Han","year":"2015","unstructured":"Han J, Lin K, Sequeira C, Borchers CH. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography\u2013tandem mass spectrometry. Anal Chim Acta. 2015;854:86\u201394.","journal-title":"Anal Chim Acta"},{"issue":"7","key":"536_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135.","journal-title":"Nat Methods"},{"issue":"43","key":"536_CR41","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LD, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"issue":"4","key":"536_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/106689690301100406","volume":"11","author":"JC Papadimitriou","year":"2003","unstructured":"Papadimitriou JC, Cangro CB, Lustberg A, Khaled A, Nogueira J, Wiland A, et al. Histologic features of mycophenolate Mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol. 2003;11(4):295\u2013302.","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"536_CR43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/his.12222","volume":"63","author":"G Liapis","year":"2013","unstructured":"Liapis G, Boletis J, Skalioti C, Bamias G, Tsimaratou K, Patsouris E, et al. Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology. 2013;63(5):649\u201358.","journal-title":"Histopathology."},{"key":"536_CR44","doi-asserted-by":"crossref","unstructured":"Heischmann S, Dzieciatkowska M, Hansen K, Leibfritz D, Christians U. The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model. Sci Rep. 2017;7:45088.","DOI":"10.1038\/srep45088"},{"issue":"9","key":"536_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):1\u201318.","journal-title":"Genome Biol"},{"issue":"34","key":"536_CR46","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, Amand ALS, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"536_CR47","doi-asserted-by":"publisher","first-page":"e0156334","DOI":"10.1371\/journal.pone.0156334","volume":"11","author":"J Park","year":"2016","unstructured":"Park J, Kotani T, Konno T, Setiawan J, Kitamura Y, Imada S, et al. Promotion of intestinal epithelial cell turnover by commensal Bacteria: role of short-chain fatty acids. PLoS One. 2016;11(5):e0156334.","journal-title":"PLoS One"},{"key":"536_CR48","doi-asserted-by":"crossref","unstructured":"Lukovac S, Belzer C, Pellis L, Keijser BJ, de Vos WM, Montijn RC, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio. 2014;5:e01438\u201314.","DOI":"10.1128\/mBio.01438-14"},{"issue":"4","key":"536_CR49","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/00365521.2019.1595708","volume":"54","author":"B Tan","year":"2019","unstructured":"Tan B, Luo W, Shen Z, Xiao M, Wu S, Meng X, et al. Roseburia intestinalis inhibits oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis. Scand J Gastroenterol. 2019;54(4):432\u201340.","journal-title":"Scand J Gastroenterol"},{"key":"536_CR50","doi-asserted-by":"crossref","unstructured":"Ji J, Shu D, Zheng M, Wang J, Luo C, Wang Y, et al. Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci Rep. 2016;6:24838.","DOI":"10.1038\/srep24838"},{"key":"536_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jnutbio.2018.03.007","volume":"57","author":"Y Tian","year":"2018","unstructured":"Tian Y, Xu Q, Sun L, Ye Y, Ji G. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development. J Nutr Biochem. 2018;57:103\u20139.","journal-title":"J Nutr Biochem"},{"issue":"24","key":"536_CR52","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1111\/bph.14085","volume":"175","author":"EM Bik","year":"2018","unstructured":"Bik EM, Ugalde JA, Cousins J, Goddard AD, Richman J, Apte ZS. Microbial biotransformations in the human distal gut. Br J Pharmacol. 2018;175(24):4404\u201314.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"536_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.1983.03340010031024","volume":"250","author":"GF Washer","year":"1983","unstructured":"Washer GF, Schr\u00f6ter GPJ, Starzl TE, Iii RW. Causes of death after kidney transplantation. JAMA. 1983;250(1):49\u201354.","journal-title":"JAMA."},{"key":"536_CR54","doi-asserted-by":"crossref","unstructured":"Stepanova M, Henry L, Garg R, Kalwaney S, Saab S, Younossi Z. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis. BMC Gastroenterol. 2015;15:175.","DOI":"10.1186\/s12876-015-0407-y"},{"key":"536_CR55","doi-asserted-by":"crossref","unstructured":"Liu F-C, Lin H-T, Lin J-R, Yu H-P. Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients. Ther Clin Risk Manag. 2017;13:1043\u201351.","DOI":"10.2147\/TCRM.S142348"},{"issue":"7","key":"536_CR56","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58(7):1509.","journal-title":"Diabetes."},{"issue":"8","key":"536_CR57","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/jcb.25902","volume":"118","author":"L Zhang","year":"2017","unstructured":"Zhang L, Du J, Yano N, Wang H, Zhao YT, Patricia D-S, et al. Sodium butyrate protects against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice HHS public access. J Cell Biochem. 2017;118(8):2395\u2013408.","journal-title":"J Cell Biochem"},{"issue":"7","key":"536_CR58","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3889\/oamjms.2019.264","volume":"7","author":"G Severova-Andreevska","year":"2019","unstructured":"Severova-Andreevska G, Danilovska I, Sikole A, Popov Z, Ivanovski N. Hypertension after kidney transplantation: clinical significance and Therapeutical aspects. Open Access Maced J Med Sci. 2019;7(7):1241.","journal-title":"Open Access Maced J Med Sci"},{"issue":"9","key":"536_CR59","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1097\/HJH.0000000000001378","volume":"35","author":"L Wang","year":"2017","unstructured":"Wang L, Zhu Q, Lu A, Liu X, Zhang L, Xu C, et al. Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro) renin receptor and intrarenal renin-angiotensin system. J Hypertens. 2017;35(9):1899\u2013908.","journal-title":"J Hypertens"},{"issue":"s7","key":"536_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/1469-0691.12687","volume":"20","author":"C Cervera","year":"2014","unstructured":"Cervera C, van Delden C, Gavald\u00e0 J, Welte T, Akova M, Carratal\u00e0 J. Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(s7):49\u201373.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"536_CR61","doi-asserted-by":"publisher","first-page":"4555562","DOI":"10.21037\/apm-21-777","volume":"10","author":"M Jin","year":"2021","unstructured":"Jin M, Zeng L, Zhang W, Deng X, Li J, Zhang W. Clinical features of multidrug-resistant organism infections in early postoperative solid organ transplantation in a single center. Ann Palliat Med. 2021;10(4):4555562\u20134562.","journal-title":"Ann Palliat Med"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-021-00536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-021-00536-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-021-00536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T21:51:17Z","timestamp":1699739477000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-021-00536-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s40360-021-00536-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Regional Ethics Committee for Animal Experimentation (CEEA-033, R\u00e9gion Limousin) and the French Ministry of Higher Education, Research and Innovation, under Project Authorization for the use of Animals for Scientific Purposes 23785-2020012416174896 v3, approved animal care and experimental procedures. These experimental procedures were performed in accordance with the guidelines for animal experimentation of the European Communities Council Directive (EU\/63\/2010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}